Cholesterol and fatty acids in cocaine addiction relapse
可卡因成瘾复发中的胆固醇和脂肪酸
基本信息
- 批准号:6506558
- 负责人:
- 金额:$ 16.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-09-27 至 2005-07-31
- 项目状态:已结题
- 来源:
- 关键词:cholesterol clinical research cocaine craving drug addiction drug detection fatty acids fish free fatty acids human subject longitudinal human study nutrient intake activity nutrition related tag psychological tests relapse /recurrence serotonin substance abuse epidemiology substance abuse related disorder tryptophan unsaturated fatty acids
项目摘要
DESCRIPTION (provided by applicant): The goal of this project is to determine whether our preliminary findings of significant associations between low circulating levels of cholesterol and of some polyunsaturated fatty acids (PUFAs) and the relapse rate of detoxified cocaine addicts can be replicated in a larger population sample. Attempts will be also made to determine whether some factors such as poor nutritional habits contribute to the presence of altered cholesterol values or fatty acid profiles in some patients.
The role of cholesterol and PUFAs has not been investigated in addictive disorders but our data can be understood in light of recent literature suggesting the existence of associations between low cholesterol levels and a number of psychiatric disorders including depression, suicide and violence. Cholesterol does not cross the blood-brain barrier but it has been suggested that it could be a marker for changes in PUFAs. There is mounting evidence that low levels of some PUFAs are also associated with a variety of psychiatric disorders. Some PUFAs are main components of neuronal synaptic membranes and influence neuronal function. Preclinical studies have demonstrated that PUFAs influence the function of dopamine and 5-HT that play a role in reward mechanisms.
One hundred and twenty cocaine addicts admitted to a Substance Abuse Inpatient Unit will be studied. While on the ward, they will undergo assessments of cholesterol and its subfractions and of the entire fatty acids series. After discharge, they will be transferred to a Substance Abuse clinic where follow-up assessments will be conducted for 12 months. The primary outcome measures will be time to relapse as determined monthly by qualitative urine and selfreported use. Psychosocial functioning, cocaine craving and dietary intake will also be monitored monthly. Cholesterol and fatty acids will be determined every 3 months.
If our preliminary findings are confirmed, the use of fatty acids supplements or changes in dietary habits could have a significant potential in the prevention of relapse in a subgroup of cocaine addicts.
描述(由申请人提供):本项目的目标是确定我们的初步发现,即低循环胆固醇水平和某些多不饱和脂肪酸(PUFA)与脱毒可卡因成瘾者的复吸率之间的显著相关性是否可以在更大的人群样本中复制。还将尝试确定某些因素,如不良的营养习惯,是否有助于改变某些患者的胆固醇值或脂肪酸谱。
胆固醇和多不饱和脂肪酸在成瘾性疾病中的作用尚未研究,但我们的数据可以根据最近的文献来理解,这些文献表明低胆固醇水平与许多精神疾病(包括抑郁症、自杀和暴力)之间存在关联。胆固醇不能穿过血脑屏障,但有人认为它可能是PUFA变化的标志物。越来越多的证据表明,低水平的某些PUFA也与各种精神疾病有关。一些PUFA是神经元突触膜的主要成分,并影响神经元功能。临床前研究表明,PUFAs影响多巴胺和5-HT的功能,在奖励机制中发挥作用。
一百二十可卡因成瘾者承认的物质滥用住院单位将进行研究。在病房里,他们将接受胆固醇及其亚组分和整个脂肪酸系列的评估。出院后,他们将被转移到药物滥用诊所,在那里进行为期12个月的随访评估。主要结局指标为每月通过尿液定性和自我报告使用确定的复发时间。还将每月监测心理社会功能、可卡因渴望和饮食摄入。每3个月测定一次胆固醇和脂肪酸。
如果我们的初步研究结果得到证实,使用脂肪酸补充剂或改变饮食习惯可能在预防可卡因成瘾者的复吸方面具有重要的潜力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LAURE B BUYDENS-BRANCHEY其他文献
LAURE B BUYDENS-BRANCHEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LAURE B BUYDENS-BRANCHEY', 18)}}的其他基金
Cholesterol and fatty acids in cocaine addiction relapse
可卡因成瘾复发中的胆固醇和脂肪酸
- 批准号:
6665101 - 财政年份:2002
- 资助金额:
$ 16.13万 - 项目类别:
Cholesterol and fatty acids in cocaine addiction relapse
可卡因成瘾复发中的胆固醇和脂肪酸
- 批准号:
6779169 - 财政年份:2002
- 资助金额:
$ 16.13万 - 项目类别:
EFFECTS OF BUSPIRONE IN WITHDRAWAL FROM OPIATES
丁螺环酮对戒除阿片类药物的影响
- 批准号:
6430318 - 财政年份:2001
- 资助金额:
$ 16.13万 - 项目类别:
EFFECTS OF BUSPIRONE IN WITHDRAWAL FROM OPIATES
丁螺环酮对戒除阿片类药物的影响
- 批准号:
6664854 - 财政年份:2001
- 资助金额:
$ 16.13万 - 项目类别:
EFFECTS OF BUSPIRONE IN WITHDRAWAL FROM OPIATES
丁螺环酮对戒除阿片类药物的影响
- 批准号:
6523213 - 财政年份:2001
- 资助金额:
$ 16.13万 - 项目类别:
COCAINE ABUSE AND ALTERATIONS IN SEROTONERGIC FUNCTION
可卡因滥用和血清素功能的改变
- 批准号:
2122727 - 财政年份:1994
- 资助金额:
$ 16.13万 - 项目类别:
COCAINE ABUSE AND ALTERATIONS IN SEROTONERGIC FUNCTION
可卡因滥用和血清素功能的改变
- 批准号:
2122728 - 财政年份:1994
- 资助金额:
$ 16.13万 - 项目类别:
COCAINE ABUSE AND ALTERATIONS IN SEROTONERGIC FUNCTION
可卡因滥用和血清素功能的改变
- 批准号:
2122729 - 财政年份:1994
- 资助金额:
$ 16.13万 - 项目类别:
相似海外基金
CLINICAL RESEARCH CENTER FOR OPIOID AND COCAINE ABUSE
阿片类药物和可卡因滥用临床研究中心
- 批准号:
2695815 - 财政年份:1986
- 资助金额:
$ 16.13万 - 项目类别:
CLINICAL RESEARCH CENTER FOR OPIOID AND COCAINE ABUSE
阿片类药物和可卡因滥用临床研究中心
- 批准号:
2116943 - 财政年份:1986
- 资助金额:
$ 16.13万 - 项目类别:
CLINICAL RESEARCH CENTER FOR OPIOID AND COCAINE ABUSE
阿片类药物和可卡因滥用临床研究中心
- 批准号:
3105363 - 财政年份:1986
- 资助金额:
$ 16.13万 - 项目类别:
CLINICAL RESEARCH CENTER FOR OPIOID AND COCAINE ABUSE
阿片类药物和可卡因滥用临床研究中心
- 批准号:
3105357 - 财政年份:1986
- 资助金额:
$ 16.13万 - 项目类别:
CLINICAL RESEARCH CENTER FOR OPIOID AND COCAINE ABUSE
阿片类药物和可卡因滥用临床研究中心
- 批准号:
2012861 - 财政年份:1986
- 资助金额:
$ 16.13万 - 项目类别:
CLINICAL RESEARCH CENTER FOR OPIOID AND COCAINE ABUSE
阿片类药物和可卡因滥用临床研究中心
- 批准号:
2837847 - 财政年份:1986
- 资助金额:
$ 16.13万 - 项目类别:
CLINICAL RESEARCH CENTER FOR OPIOID AND COCAINE ABUSE
阿片类药物和可卡因滥用临床研究中心
- 批准号:
3105362 - 财政年份:1986
- 资助金额:
$ 16.13万 - 项目类别:
CLINICAL RESEARCH CENTER FOR OPIOID AND COCAINE ABUSE
阿片类药物和可卡因滥用临床研究中心
- 批准号:
3105360 - 财政年份:1986
- 资助金额:
$ 16.13万 - 项目类别:
CLINICAL RESEARCH CENTER FOR OPIOID AND COCAINE ABUSE
阿片类药物和可卡因滥用临床研究中心
- 批准号:
2116945 - 财政年份:1986
- 资助金额:
$ 16.13万 - 项目类别:
CLINICAL RESEARCH CENTER FOR OPIOID AND COCAINE ABUSE
阿片类药物和可卡因滥用临床研究中心
- 批准号:
3105365 - 财政年份:1986
- 资助金额:
$ 16.13万 - 项目类别: